Population-based analysis of occult primary breast cancer with axillary lymph node metastasis

Cancer

Volumn 116, Issue 17, 2010, Pages 4000-4006

  Walker, Gary V ^a   Smith, Grace L ^a   Perkins, George H ^a   Oh, Julia L ^a   Woodward, Wendy ^a   Yu, Tse Kuan ^a   Hunt, Kelly K ^a   Hoffman, Karen ^a   Strom, Eric A ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Axillary lymph node metastasis; Breast conserving therapy; End results; Epidemiology; Mastectomy; Occult breast cancer; Surveillance

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ADJUVANT THERAPY; AXILLA; BREAST NEOPLASMS; CANCER REGISTRY; HEALTH SURVEY; LYMPH NODE DISSECTION; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASMS, HORMONE-DEPENDENT; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POPULATION SURVEILLANCE; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; TREATMENT OUTCOME;

EID: 77956866487     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25197     Document Type: Article

References (24)

1. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology, Breast Cancer v1.2009. Available at: http://www.nccn.org/professionals/physician-gls/PDF/breast.pdf. Accessed August 28, 2009.
2. Vlastos G, Jean ME, Mirza AN, et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001;8:425-431.
3. Foroudi F, Tiver KW. Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys. 2000;47:143-147.
4. Shannon C, Walsh G, Sapunar F, A'Hern R, Smith I. Occult primary breast carcinoma presenting as axillary lymphadenopathy. Breast. 2002;11:414-418.
5. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer. 1995;76:2343-2350.
6. National Cancer Institute. SEER Registries - Population Characteristics. Available at: http://seer.cancer.gov/registries/characteristics.html. Accessed September 15, 2009.
7. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) Program. Available at: http://seer.cancer.gov/. Accessed August 28, 2009.
8. Surveillance, Epidemiology, and End Results (SEER) Program. SEER/Stat database: Incidence-SEER 17 Registries limited-use plus Hurricane Katrina impacted Louisiana cases, November 2008 submission (1973-2006 varying). Linked to county attributes-total US, 1969-2006 counties. Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2009, based on the November 2008 submission.
9. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
10. Housman DM, Decker RH, Wilson LD. Regarding adjuvant radiation therapy in Merkel cell carcinoma: selection bias and its affect on overall survival. J Clin Oncol 25:4503-4504, 2007; author reply 4504-4505.
11. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14:1558-1564.
12. Blanchard DK, Farley DR. Retrospective study of women presenting with axillary metastases from occult breast carcinoma. World J Surg. 2004;28:535-539.
13. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
14. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822-828. (Pubitemid 19094701)
15. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial. Cancer. 2003;98:697-702.
16. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-1150.
17. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
18. Merson M, Andreola S, Galimberti V, Bufalino R, Marchini S, Veronesi U. Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer. 1992;70:504-508.
19. Campana F, Fourquet A, Ashby MA, et al. Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut Curie. Radiother Oncol. 1989;15:321-325.
20. Vilcoq JR, Calle R, Ferme F, Veith F. Conservative treatment of axillary adenopathy due to probable subclinical breast cancer. Arch Surg. 1982;117:1136-1138.
21. Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology. 2006;71:456-459.
22. Galimberti V, Bassani G, Monti S, et al. Clinical experience with axillary presentation breast cancer. Breast Cancer Res Treat. 2004;88:43-47.
23. Olson JA Jr, Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411-415.
24. Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol. 2005;12:1045-1053.